Henryk T Dudek

USPTO Granted Patents = 60 (Patent Applications = 26)

CIPO Patents = 2 (Patent Applications = 24)

EPO Patents = 9 (Patent Applications = 32)

Average Co-Inventor Count = 2.4

ph-index = 6

Forward Citations = 219(Granted Patents)

Forward Citations (Not Self Cited) = 168(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Cambridge, MA (US) (2021)
Wellesley, MA (US) (2001 - 2024)
Lexington, MA (US) (2022 - 2024)
Belmont, MA (US) (2023 - 2024)

Company Filing History:

55 out of 99

Dicerna Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

Areas of Expertise:

LPA Expression

APOC3 Expression

PNPLA3 Expression

TMPRSS6 Expression

Alpha-1 Antitrypsin

Glycolate Oxidase

Transthyretin

Antithrombin 3

Lactate Dehydrogenase

PCSK9 Oligonucleotides

HIF-1 Alpha

Androgen Receptor

60 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12435336 - Compositions and methods for inhibiting LPA expression (2025-10-07),

2. 12252691 - Compositions and methods for inhibiting LPA expression (2025-03-18),

3. 12234456 - Compositions and methods for modulating APOC3 expression (2025-02-25),

4. 12084662 - Compositions and methods for modulating PNPLA3 expression (2024-09-10),

5. 11952574 - Compositions and methods for inhibiting transmembrane serine protease 6 (TMPRSS6) expression (2024-04-09),

6. 11912996 - Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA (2024-02-27),

7. 11873493 - Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA (2024-01-16),

8. 11851658 - Methods and compositions for the specific inhibition of alpha-1 antitrypsin by double-stranded RNA (2023-12-26),

9. 11773390 - Methods and compositions for the specific inhibition of Complement Component 5(C5) by double-stranded RNA (2023-10-03),

10. 11697812 - Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA (2023-07-11),

11. 11667918 - Methods and compositions for the specific inhibition of antithrombin 3 (AT3) by double-stranded RNA (2023-06-06),

12. 11661604 - Methods and compositions for inhibiting expression of LDHA (2023-05-30),

13. 11655473 - Compositions and methods for inhibiting mitochondria amidoxime reducing component 1 (MARC1) expression (2023-05-23),

14. 11578329 - Compositions and methods for inhibiting nuclear receptor subfamily 1 group H member 3 (NR1H3) expression (2023-02-14),

15. 11572562 - Compositions and methods for inhibiting GYS2 expression (2023-02-07),

Title: Henryk T Dudek: Pioneering Inventor from Wellesstate, MA

Introduction: Henryk T Dudek is a renowned inventor hailing from Wellesley, MA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Henryk T Dudek holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing cutting-edge solutions for modern challenges.

Career Highlights: Throughout his illustrious career, Henryk T Dudek has consistently pushed the boundaries of innovation, with his inventions revolutionizing industries and improving the lives of many.

Collaborations: Henryk T Dudek has collaborated with leading tech companies, research institutions, and universities, fostering a culture of innovation and knowledge-sharing to drive progress in the field.

Conclusion: Henryk T Dudek's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a trailblazing inventor, leaving a lasting impact on the world of technology.

This text is generated by artificial intelligence and may not be accurate.